A phase 3 trial of intralesional cemiplimab in patients with early-stage cutaneous SCC, newly underway at GW and multiple other sites, will look at how well the immune checkpoint inhibitor ... from ...

India's top drugmakers are reportedly sitting on their highest cash reserves in at least five years, up over 120% from FY20 ...

Sun Pharma anticipates revenue growth for fiscal year 26, building on an 8% increase in fiscal year 25. However, increased spending on marketing specialty products may impact profitability. Net profit ...

Sun Pharma will also launch skin cancer drug Unloxcyt in FY26. The drug was incorporated into Sun’s portfolio after the acquisition of Checkpoint Therapeutics in March this year for an upfront ...

Sun Pharmaceutical Industries has lined up a $100 million investment to commercialise innovative products in the current fiscal, according to Chairman and Managing Director Dilip Shanghvi.

CHENNAI: India’s largest drug maker, Sun Pharmaceutical Industries, has completed its acquisition of US-based Checkpoint Therapeutics for approximately $355 mil ...

Sun Pharmaceutical Industries on Friday announced the successful completion of its acquisition of Checkpoint Therapeutics, Inc. (Checkpoint), an immunotherapy and targeted oncology company.

The merger arrives as Checkpoint Therapeutics, Inc. (NASDAQ:CKPT)’s market cap stands at $370.71 million. With the deal valued at $416 million, the premium paid by Sun Pharma signals confidence ...

Checkpoint Therapeutics, Inc. announced the completion of a merger on May 30, 2025, with Snoopy Merger Sub, Inc., a wholly owned subsidiary of Sun Pharmaceutical Industries, Inc. As part of the ...

Upon completion of the transaction, Sun Pharma acquired all outstanding shares of Checkpoint for $4.10 per share in cash and a non-transferable CVR entitling the stockholder to receive up to an ...

Sun Pharma has acquired all outstanding shares of Checkpoint at a price of $4.10 per share in cash, without interest, plus one non-tradable contingent value right (CVR) per share representing the ...